9robes

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., Docket No. 24-889

5 min · I går
episode Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., Docket No. 24-889 cover

Beskrivelse

This ruling protects generic drug competition while still holding companies accountable if they cross the line into deliberately promoting patented uses. For patients and consumers, it means generic drugs will remain a competitive force in the market. For brand-name companies, it means they need clear evidence of intentional wrongdoing, not just circumstantial suggestions, to win these lawsuits. music for the podcast provided by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dimitry Taras [https://pixabay.com/music/upbeat-upbeat-energetic-rock-fun-happy-travel-background-254065/]

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av 9robes sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

149 Episoder